Adia Med hires Lucosky Brookman as counsel for planned Nasdaq uplisting

• Adia Med engaged Lucosky Brookman as legal counsel for a planned uplisting from OTC Markets to the Nasdaq Capital Market.
• The firm will handle preparation of an S-1 registration statement, related due diligence, and responses to regulator comments.
• Work also covers the Nasdaq listing application, including amendments and comment responses, as the company advances the listing process.
• Post-listing support would include ongoing reporting compliance, Section 16 filings, basic 8-K filings, and review of basic press releases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Med Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608240800NEWSFILECNPR____20260824_310842_1) on August 24, 2026, and is solely responsible for the information contained therein.